Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01464632

Post-Market Study of the EPIK Knee System

Prospective, Open Label Study of the Short-and Midterm Safety and Efficacy of the EPIK Uni-Compartmental Knee System in Community Practice

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Encore Medical, L.P. · Industry
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the short-term (2 yr) and midterm (5 yr) cumulative revision rates of the EPIK™ Uni-compartmental Knee System.

Detailed description

Medial uni-compartmental knee replacement (UKA) has been used for over 40 years to treat osteoarthritis (OA) of the knee. It is becoming more widely accepted as a treatment for early stage OA of the knee in order to preserve bony and ligamentous structures. The majority of the subjects who have received this knee are older (over 65 yrs) however, it is being used increasingly more frequently in younger individuals who have uni-compartmental knee disease so that bone may be spared in case the need arises in the future for a total knee arthroplasty. The study will take place at two sites within the United States and be managed by the Clinical Affairs Department at DJO Surgical in Austin, TX. The study will include only subjects who meet the indications for use criteria for the EPIK™ Uni-compartmental Knee System and who are candidates for UKA. Investigators will enroll up to 60 subjects at each of 2 sites within the United States, for a total of 100 subjects maximum.

Conditions

Interventions

TypeNameDescription
DEVICEEPIK™ uni-compartmental kneeThis device is intended for partial replacement of the articulating surfaces of the knee when only one side of the joint is affected due to compartmental primary degenerative or post-traumatic degenerative disease, previous tibial condyle or plateau fractures, deformity, or revision of previous arthroplasty.

Timeline

Start date
2011-11-01
Primary completion
2012-05-01
Completion
2012-05-01
First posted
2011-11-03
Last updated
2012-05-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01464632. Inclusion in this directory is not an endorsement.